The U.S. IVF market size was valued at $4,905.46 million in 2020, and is expected to reach $5,563.06 million by 2027, registering a CAGR of 6.8% from 2019 to 2027.
The European IVF market was valued at $3,054 million in 2015 and is estimated to reach $4,447 million by 2022, growing at a CAGR of 5.4% during the analysis period.
The global ambulatory ehr market was valued at $6.1 billion in 2023, and is projected to reach $11.1 billion by 2033, growing at a CAGR of 6.3% from 2024 to 2033.
Severe combined immunodeficiency (SCID) is a set of rare disorders caused by various gene mutations. These genes are responsible for the development and functioning of the immune system.
